Clinical Trials
2
Active:0
Completed:0
Trial Phases
2 Phases
Phase 2:1
Not Applicable:1
Drug Approvals
1
FDA:1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (50.0%)Phase 2
1 (50.0%)Comparing Lorcaserin Versus Duloxetine for the Treatment of Chemotherapy-Induced Peripheral Neuropathy
Phase 2
- Conditions
- Chemotherapy-Induced Peripheral Neuropathy
- Interventions
- First Posted Date
- 2019-01-23
- Last Posted Date
- 2019-04-04
- Lead Sponsor
- Southeastern Regional Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT03812523
- Locations
- 🇺🇸
Cancer Treatment Centers of America - Atlanta, Newnan, Georgia, United States
Improved Method of Detecting Cancer Metastases
Not Applicable
- Conditions
- Endometrial Carcinoma
- First Posted Date
- 2015-02-20
- Last Posted Date
- 2015-02-20
- Lead Sponsor
- Southeastern Regional Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT02368067
- Locations
- 🇺🇸
Southeastern Regional Medical Center, Newnan, Georgia, United States
News
No news found